Detecting cognitive impairment in patients with schizophrenia with the Addenbrooke's Cognitive Examination.

07:00 EST 17th January 2019 | BioPortfolio

Summary of "Detecting cognitive impairment in patients with schizophrenia with the Addenbrooke's Cognitive Examination."

To assess the feasibility of the Addenbrooke's Cognitive Examination III (ACE) in detecting cognitive deficits in people with schizophrenia and to examine the profile of cognitive impairments.


Journal Details

This article was published in the following journal.

Name: Asian journal of psychiatry
ISSN: 1876-2026
Pages: 19-22


DeepDyve research library

PubMed Articles [29810 Associated PubMed Articles listed on BioPortfolio]

Diagnostic accuracy of the Thai version of the Mini-Addenbrooke's Cognitive Examination as a mild cognitive impairment and dementia screening test.

To examine the diagnostic accuracy of the Thai version of the Mini-Addenbrooke's Cognitive Examination (MACE-T) for detecting mild cognitive impairment and dementia.

The Mini-Addenbrooke's Cognitive Examination (M-ACE) as a brief cognitive screening instrument in Mild Cognitive Impairment and mild Alzheimer's disease.

The Mini-Addenbrooke's Cognitive Examination (M-ACE) is a brief cognitive screening test that evaluates four main cognitive domains (orientation, memory, language and visuospatial function) with a max...

A promising structural magnetic resonance imaging assessment in patients with preclinical cognitive decline and diabetes mellitus.

Subjective cognitive decline (SCD) is frequently reported in diabetic patients. Diabetes mellitus (DM) is associated with changes in the microstructure of the brain arise in diabetic patients, includi...

Evidence for an association of serum melatonin concentrations with recognition and circadian preferences in patients with schizophrenia.

Melatonin, a neuro-differentiation factor, may play a role in the neurodevelopmental origins of schizophrenia. Cognitive impairment and decreased melatonin are reported in schizophrenia; however, the ...

Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.

Brain-derived neurotrophic factor (BDNF) may be related to the pathophysiology of schizophrenia. This study aims to examine the relation between plasma BDNF levels and the cognition of patients with s...

Clinical Trials [7355 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

To establish the proof of concept that MEM 3454, used as add-on pharmacotherapy, is a safe and effective treatment in patients with cognitive impairment associated with schizophrenia (CIAS...

MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia.

The purpose of this study is to determine the safety and effectiveness of an investigational drug for the treatment of cognitive impairment in patients with schizophrenia.

Validation of a German Translation and Cultural Adaptation of the Addenbrooke's Cognitive Examination III

The aim of the entire project was to perform a translation and cultural adaptation of the Addenbrooke's Cognitive Examination - III (ACE-III), adhering to the Translation and Cultural Adap...

Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone

In this study we intend to compare the effect of Sertindole to that of Risperidone on cognitive impairment in schizophrenia. Hypothesis: Sertindole will be as effective as Risperidone for...

A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

The purpose of this study is to determine whether PF-04958242 is safe and effective in the treatment of cognitive dysfunction in schizophrenia subjects

Medical and Biotech [MESH] Definitions

A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD.

Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).

A condition of low alertness or cognitive impairment, usually associated with prolonged mental activities or stress.

A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination.

A type of schizophrenia characterized by abnormality of motor behavior which may involve particular forms of stupor, rigidity, excitement or inappropriate posture.

Quick Search

DeepDyve research library

Relevant Topic

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Searches Linking to this Article